NASDAQ: NAOV - NanoVibronix, Inc.

Rentabilität für sechs Monate: -44%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan NanoVibronix, Inc.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen NanoVibronix, Inc.

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.

weitere details
The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2017-06-27
ISIN US63008J1088
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.nanovibronix.com
Цена ао 3.89
Preisänderung pro Tag: -3.58% (3.91)
Preisänderung pro Woche: -14.12% (4.39)
Preisänderung pro Monat: +5.42% (3.5761)
Preisänderung über 3 Monate: -40.93% (6.3822)
Preisänderung über sechs Monate: -44% (6.732)
Preisänderung pro Jahr: +318.89% (0.9)
Preisänderung über 3 Jahre: +314.51% (0.9095)
Preisänderung über 5 Jahre: +35.74% (2.7774)
Preisänderung seit Jahresbeginn: -40.93% (6.3822)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 0.7896 9
P/BV 0.452 10
P/E 0 0
EV/EBITDA 0.4295 10
Gesamt: 6.13

Effizienz

Name Bedeutung Grad
ROA, % -55.6 0
ROE, % -93.05 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -0.0015 10
Gesamt: 9.8

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 330.75 10
Rentabilität Ebitda, % -38.66 0
Rentabilität EPS, % -87.3 0
Gesamt: 2
Weitere Details

Institutionen Volumen Aktie, %
Renaissance Technologies, LLC 41200 1.48
Vanguard Group Inc 30194 1.08
Geode Capital Management, LLC 14461 0.52
Amtrust Financial Services, Inc. 12408 0.45
Tower Research Capital LLC (TRC) 5262 0.19
UBS Group AG 3537 0.13
National Bank of Canada/FI 110 0
Blackrock Inc. 74 0
Wells Fargo & Company 13 0
Morgan Stanley 10 0



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Brian M. Murphy CEO & Director 382.5k 1957 (68 Jahre)
Mr. Stephen R. Brown CPA Chief Financial Officer 292.5k 1956 (69 Jahre)
Dr. Harold Jacob M.D. Chief Medical Officer & Director N/A 1954 (71 Jahr)
Mr. Amir Rippel Vice President of Marketing N/A
Ms. Lindsey Harrison Vice President of Sales N/A

Adresse: United States, Elmsford. NY, 525 Executive Boulevard - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.nanovibronix.com